Louis P Garrison (Louis Garrison)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Future oncology (London, England)

Journal of medical economics

American journal of medical genetics. Part C, Seminars in medical genetics

Cost effectiveness and resource allocation : C/E

University of Washington

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Washington

United States

Professor Emeritus :: Pharmacy

Publications

William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) (2024)
William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) (2024)
William Bruce Wong, Stacey Kowal, Tu My To, Achal Patel, David L Veenstra, Louis P Garrison, Meng Li
The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations. Future oncology (London, England) 20 (16) (2024)
Louis P Garrison, Andrew W Lo, Richard S Finkel, Patricia A Deverka
A review of economic issues for gene-targeted therapies: Value, affordability, and access. American journal of medical genetics. Part C, Seminars in medical genetics 193 (1) (2023)
Louis P Garrison, Andrew W Lo, Richard S Finkel, Patricia A Deverka
A review of economic issues for gene-targeted therapies: Value, affordability, and access. American journal of medical genetics. Part C, Seminars in medical genetics (2023)
Louis P Garrison, Elisabeth Sophia Hartgers-Gubbels, Michael Chambers
Value Insider Season 1 Episode 5: What Other Aspects of Value May Be Relevant? (Societal Impact) [Podcast]. International journal of general medicine 15 (2022)
Woojung Lee, William Bruce Wong, Stacey Kowal, Louis P Garrison, David L Veenstra, Meng Li
Modeling the Ex Ante Clinical Real Option Value in an Innovative Therapeutic Area: ALK-Positive Non-Small-Cell Lung Cancer. PharmacoEconomics 40 (6) (2022)
Jipan Xie, Yan Wang, Yaping Xu, Jennifer T Fine, Jenny Lam, Louis P Garrison
Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial. Journal of medical economics 25 (1) (2021)
Louis P Garrison, Patricia Schepman, Andrew G Bushmakin, Rebecca L Robinson, Leslie Tive, Jerry Hall, Mendwas Dzingina, James Jackson, Mia Berry, Joseph Christopher Cappelleri, Stuart L Silverman
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2021)
Bernarda Zamora, Louis P Garrison, Aig Unuigbe, Adrian Towse
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting? Cost effectiveness and resource allocation : C/E 19 (1) (2021)
Boshen Jiao, Louis P Garrison
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer. Expert review of pharmacoeconomics & outcomes research 21 (3) (2021)
Keziah Cook, Shaun P Forbes, Kelly Adamski, Janice J Ma, Anita Chawla, Louis P Garrison
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A. Journal of medical economics 23 (5) (2020)

Louis P Garrison.css-eqlu8i{font-size:small;padding-left:4px;} (Louis Garrison)

Publication Activity (10 Years)

Top Topics

Top Venues

Louis P Garrison (Louis Garrison)